Literature DB >> 19569199

Mobile phase containing arginine provides more reliable SEC condition for aggregation analysis.

Ryosuke Yumioka1, Haruna Sato, Hiroshi Tomizawa, Yosuke Yamasaki, Daisuke Ejima.   

Abstract

Loss of protein aggregates due to matrix protein interaction during SEC often causes underestimation of aggregate content in the quality control of pharmaceutical proteins. Since new columns especially show stronger tendency to bind proteins, an effort should be made to suppress protein adsorption. We examined the effects of arginine on protein binding to SEC columns and found that loss of aggregates was reduced in the presence of arginine, leading to a reliable estimate of aggregate content even with newly used column and small protein load. This is not due to increased ionic strength, as NaCl resulted in increased protein loss. (c) 2009 Wiley-Liss, Inc. and the American Pharmacists Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19569199     DOI: 10.1002/jps.21857

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution.

Authors:  Indu Javeri; Kaliappanadar Nellaiappan; Charles McNemar; Kirill Yakovlevsky; Amina Soukrati; Phanindra Velisetty; Bijay Misra
Journal:  Pharm Res       Date:  2018-06-26       Impact factor: 4.200

2.  Expanding the toolbox for predictive parameters describing antibody stability considering thermodynamic and kinetic determinants.

Authors:  Michaela Blech; Richard Melien; Nuska Tschammer; Beate Presser; Dariush Hinderberger; Patrick Garidel
Journal:  Pharm Res       Date:  2021-12-13       Impact factor: 4.200

3.  Strategies for the assessment of protein aggregates in pharmaceutical biotech product development.

Authors:  John den Engelsman; Patrick Garidel; Ronald Smulders; Hans Koll; Bryan Smith; Stefan Bassarab; Andreas Seidl; Otmar Hainzl; Wim Jiskoot
Journal:  Pharm Res       Date:  2010-10-23       Impact factor: 4.200

4.  Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins.

Authors:  Elena Krayukhina; Kouhei Tsumoto; Susumu Uchiyama; Kiichi Fukui
Journal:  J Pharm Sci       Date:  2014-09-24       Impact factor: 3.534

Review 5.  Arginine as a synergistic virucidal agent.

Authors:  Satoshi Ohtake; Tsutomu Arakawa; A Hajime Koyama
Journal:  Molecules       Date:  2010-03-08       Impact factor: 4.411

6.  Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates.

Authors:  Paula Hong; Stephan Koza; Edouard S P Bouvier
Journal:  J Liq Chromatogr Relat Technol       Date:  2012-11-30       Impact factor: 1.467

7.  [Size exclusion-reverse liquid column chromatography-mass spectrometry and its application in the identification of post-translationally modified proteins in rat kidney].

Authors:  Jianmin Li; Yue Zhuo; Yida Zhang; Na Li; Jianlin Wu
Journal:  Se Pu       Date:  2021-01

8.  Direct coupling of size exclusion chromatography and mass spectrometry for the characterization of complex monoclonal antibody products.

Authors:  Amarande Murisier; Marie Andrie; Szabolcs Fekete; Matthew Lauber; Valentina D'Atri; Katharina Iwan; Davy Guillarme
Journal:  J Sep Sci       Date:  2022-03-28       Impact factor: 3.614

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.